Kreft, Andreas; Neumann, Helmut; Schindeldecker, Mario et al.
Diagnosis and grading of acute graft-versus-host disease in endoscopic biopsy series throughout the upper and lower intestine in patients after allogenic hematopoietic stem cell transplantation: a systematic approachLEUKEMIA & LYMPHOMA. Bd. 60. H. 6. 2019 S. 1512-1521
Feil, Charlotte; Stein, Thorsten; Forster, Andreas et al.
Diagnosis of lung cancer by canine olfactory detection in urine and breath samples.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Neumann, Helmut; Grimminger, Peter P.; Zimmermann, Tim et al.
DIAGNOSTIC ABILITY OF BLUE LIGHT IMAGING FOR PREDICTING DEEP SUBMUCOSAL INVASION IN COLORECTAL LESIONSGASTROINTESTINAL ENDOSCOPY. Bd. 89. H. 6. 2019 S. AB388-AB389
Schulze, Lisa; Kreft, Andreas; Zimmermann, Tim et al.
DIAGNOSTIC YIELD OF ENDOSCOPY FOR PREDICTION OF ACUTE GRAFT VERSUS HOST DISEASE IN THE UPPER GASTROINTESTINAL TRACTGASTROINTESTINAL ENDOSCOPY. Bd. 89. H. 6. 2019 S. AB496-AB496
Ashfaq-Khan, Muhammad; Aslam, Misbah; Qureshi, Muhammad Asif et al.
Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver diseaseSCIENTIFIC REPORTS. Bd. 9. 2019
Galle, Peter R.
DISCREPANCIES BETWEEN EASL, AASLD AND APASL GUIDELINES ON HEPATOCELLULAR CARCINOMA MANAGEMENTLIVER INTERNATIONAL. Bd. 39. H. 12. 2019 S. 2459-2459
Czauderna, Carolin; Poplawski, Alicia; Castven, Darko et al.
Dissecting the landscape of (epi-)genetic alterations during sequential evolution of liver cancerJOURNAL OF HEPATOLOGY. Bd. 70. 2019 S. E358-E359
Gerard, Claude; Di-Luoffo, Mickael; Gonay, Leolo et al.
Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinomaJOURNAL OF HEPATOLOGY. Bd. 71. H. 2. 2019 S. 323-332
Galle, Peter R.; Forner, Alejandro; Llovet, Josep M. et al.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 69, pg 182, 2018)JOURNAL OF HEPATOLOGY. Bd. 70. H. 4. 2019 S. 817-817
Lawitz, Eric; Flisiak, Robert; Abunimeh, Manal et al.
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infectionLIVER INTERNATIONAL. 2019